Bromocriptine

Introduction and Mechanism of Action

Bromocriptine is an ergot alkaloid derivative that acts as a potent dopamine receptor agonist. In the context of postpartum midwifery care, its primary role is to prevent or suppress physiological lactation when medically indicated.

Normally, the hormone prolactin stimulates milk production in the alveoli of the breasts. During pregnancy, high levels of estrogen and progesterone block the milk-making action of prolactin. After delivery, the expulsion of the placenta causes a sudden drop in these placental hormones, allowing prolactin to drive lactation. Bromocriptine mimics the action of dopamine (also known as prolactin-inhibiting factor) within the anterior pituitary gland. By binding to dopamine D2 receptors, it directly inhibits the synthesis and release of prolactin, effectively switching off the hormonal signal for milk production.

Clinical Indications for Lactation Suppression

Midwives encounter lactation suppression therapy in specific clinical scenarios where breastfeeding is either impossible or clinically contraindicated for the mother or baby.

• IUD (Intrauterine Death) or Stillbirth: To prevent the psychological and physical distress of engorgement when there is no infant to feed.
• Neonatal demise: Supporting the grieving mother by reducing painful breast swelling.
• Maternal infectious diseases: Severe conditions such as active, untreated HIV infection where breastfeeding poses a high risk of vertical transmission to the newborn.
• Maternal illness: Severe debilitating psychiatric or physical conditions where the mother cannot safely care for or feed the infant.

Note that routine use of bromocriptine solely for personal preference or convenience is discouraged due to safety concerns.

Dosage, Administration, and Timing

Timing is critical for the success of bromocriptine therapy. To prevent lactation before it fully establishes, treatment usually begins within hours to days after delivery.

• Initial dose: Typically 2.5 mg given orally.
• Maintenance schedule: Usually 2.5 mg twice daily for 14 days.
• Shorter courses: If mild rebound engorgement occurs after stopping, a short extension may be used, though therapy rarely exceeds two weeks.

Midwives must advise mothers to take the medication with meals to minimize gastrointestinal upset. Absorption is optimized when food is present in the stomach, which also helps reduce the incidence of sudden nausea.

Side Effects and Adverse Reactions

While effective, bromocriptine carries a notable side effect profile that midwives must monitor closely during the early postpartum hours.

• Hypotension: The most common and significant vascular effect is a drop in blood pressure, which can cause dizziness or fainting upon standing.
• Gastrointestinal distress: Nausea, vomiting, and abdominal cramps frequently occur, particularly with the first few doses.
• Central nervous system effects: Headaches, fatigue, and lightheadedness are regularly reported by postpartum women.

Midwives should instruct mothers to rise slowly from a lying or sitting position to prevent orthostatic collapse, especially during the first 48 hours of treatment.

Contraindications and Maternal Safety Precautions

Due to its potent systemic vascular and neurological effects, bromocriptine is strictly contraindicated in several maternal conditions. Midwives must screen patient histories thoroughly before administration.

• Hypertensive disorders: Women with pre-existing chronic hypertension, pregnancy-induced hypertension, or pre-eclampsia must not receive bromocriptine due to the risk of stroke and severe vasospasm.
• Cardiovascular disease: A history of myocardial infarction or severe coronary artery disease rules out its use.
• Psychiatric history: Patients with severe psychotic disorders may experience exacerbations of their symptoms.
• Migraines: History of severe headaches can be worsened by ergot alkaloids.

Postpartum hemorrhage combined with bromocriptine use also increases cardiovascular risks, requiring stable vital signs before initiation.

Nursing Care and Patient Counseling

Comprehensive midwifery care extends beyond pill administration to encompass holistic support and vital sign monitoring. Midwives must track blood pressure readings regularly, particularly during the first few days of therapy when hypotension risks peak.

Patient counseling should cover the expected timeline of breast discomfort. Even with medication, some degree of breast fullness, tenderness, and mild leakage may occur. Reassure the mother that supportive measures—such as wearing a firm, well-fitted brassiere, applying cold compresses, and taking mild analgesics—will help manage discomfort safely. Instruct mothers to report persistent severe headaches, chest pain, or visual disturbances immediately, as these demand prompt medical evaluation.